Assessment of laboratory side effects of disease modifying drugs in a sample of multiple sclerosis patients in Ain Shams University Hospitals

Abstract

Multiple sclerosis is a chronic demyelinating disease of the central nervous system of presumed autoimmune etiology, characterized by localized areas of inflammation, demyelination, axonal loss and gliosis in the brain and spinal cord. Although the clinical presentation and course of the disease are highly variable, several disease types can be recognized, including relapsing remitting (RR), primary progressive (PP), secondary progressive (SP) and clinically isolated syndrome (CIS) (Milo and Miller, 2014).